Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0286507 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Ana Moyano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Africa Health Research Institute, KwaZulu-Natal, South Africa, Durban, South Africa. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Research Foundation Thuthuka, National Research Foundation.
Abstract (Originalsprache)
Previous work suggests that HIV controllers with protective human leukocyte antigen class I alleles (VC+) possess a high breadth of Gag-specific CD8+ T cell responses, while controllers without protective alleles (VC-) have a different unknown mechanism of control. We aimed to gain further insight into potential mechanisms of control in VC+ and VC-. We studied 15 VC+, 12 VC- and 4 healthy uninfected individuals (UI). CD8+ T cell responses were measured by ELISpot. Flow cytometry was performed to analyse surface markers for activation, maturation, and exhaustion on natural killer (NK) cell and T cells, as well as cytokine secretion from stimulated NK cells. We measured plasma neutralization activity against a panel of 18 Env-pseudotyped viruses using the TZM-bl neutralization assay. We found no significant differences in the magnitude and breadth of CD8+ T cell responses between VC+ and VC-. However, NK cells from VC- had higher levels of activation markers (HLA-DR and CD38) (p = 0.03), and lower cytokine expression (MIP-1β and TNF-α) (p = 0.05 and p = 0.04, respectively) than NK cells from VC+. T cells from VC- had higher levels of activation (CD38 and HLA-DR co-expression) (p = 0.05), as well as a trend towards higher expression of the terminal differentiation marker CD57 (p = 0.09) when compared to VC+. There was no difference in overall neutralization breadth between VC+ and VC- groups, although there was a trend for higher neutralization potency in the VC- group (p = 0.09). Altogether, these results suggest that VC- have a more activated NK cell profile with lower cytokine expression, and a more terminally differentiated and activated T cell profile than VC+. VC- also showed a trend of more potent neutralizing antibody responses that may enhance viral clearance. Further studies are required to understand how these NK, T cell and antibody profiles may contribute to differing mechanisms of control in VC+ and VC-.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Africa Health Research Institute, KwaZulu-Natal, South Africa, Durban, South Africa.
- HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
- Division of Infection and Immunity, University College London, London, United Kingdom.
- Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States of America.
ORCID-Profile: Jaclyn K Mann, Thumbi Ndung'u
Förderung
- Wellcome Trust
- National Research Foundation Thuthuka
- National Research Foundation
- International AIDS Vaccine Initiative
- Victor Daitz Foundation
- UK Foreign, Commonwealth & Development Office
Zitieren
APA
Moyano, A., Ndlovu, B., Mbele, M., Naidoo, K., Khan, N., Mann, J. K., & Ndung'u, T. (2023). Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles. PLOS ONE. https://doi.org/10.1371/journal.pone.0286507
Vancouver
Moyano A, Ndlovu B, Mbele M, Naidoo K, Khan N, Mann JK, et al. Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles. PLOS ONE. 2023. doi:10.1371/journal.pone.0286507
BibTeX
@article{Moyano2023,
author = {Moyano, Ana and Ndlovu, Bongiwe and Mbele, Msizi and Naidoo, Kewreshini and Khan, Nasreen and Mann, Jaclyn K and Ndung'u, Thumbi},
title = {Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0286507}
}
EUVIMED